It can be speculated that factors such as conformation, expression level, distribution, and interactions with other receptors on cancer cells within the TME, may play a crucial role in selectively targeting cancer cells, thereby minimizing nonspecific toxicity to CD44-positive normal cells. The gene discussed is CD44; the disease is cancer.